Kidney outcomes using a sustained ≥40% decline in eGFR: A meta-analysis of SGLT2 inhibitor trials

the VERTIS CV Investigators

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Kidney outcomes using a sustained ≥40% decline in eGFR: A meta-analysis of SGLT2 inhibitor trials'. Together they form a unique fingerprint.

Medicine & Life Sciences